Cargando…

Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis

Conventional anti-tuberculosis (TB) therapies comprise lengthy antibiotic treatment regimens, exacerbated by multi-drug resistant and extensively drug resistant mycobacterial strains. We assessed the ability of all-trans retinoic acid (ATRA), as repurposed compound serving as host-directed therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leukes, Vinzeigh N., Dorhoi, Anca, Malherbe, Stephanus T., Maasdorp, Elizna, Khoury, Justine, McAnda, Shirley, Walzl, Gerhard, du Plessis, Nelita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493473/ https://www.ncbi.nlm.nih.gov/pubmed/33865151 http://dx.doi.org/10.1016/j.cellimm.2021.104359

Ejemplares similares

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
por: du Plessis, Nelita, et al.
Publicado: (2018)

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
por: Leukes, Vinzeigh N., et al.
Publicado: (2022)

Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts
por: Kotzé, Leigh A., et al.
Publicado: (2020)

Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
por: Dorhoi, Anca, et al.
Publicado: (2018)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis
por: du Plessis, Willem J., et al.
Publicado: (2016)

The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
por: Magcwebeba, Tandeka, et al.
Publicado: (2019)

Corrigendum: The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
por: Magcwebeba, Tandeka, et al.
Publicado: (2019)

Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases
por: Kotze, Leigh Ann, et al.
Publicado: (2022)

The Peripheral Blood Transcriptome Is Correlated With PET Measures of Lung Inflammation During Successful Tuberculosis Treatment
por: Odia, Trust, et al.
Publicado: (2021)

Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa
por: Hiemstra, Andriёtte M., et al.
Publicado: (2022)

Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology
por: Munansangu, Brian S. M., et al.
Publicado: (2022)

Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa
por: Shaw, Jane Alexandra, et al.
Publicado: (2021)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells
por: John, Vini, et al.
Publicado: (2019)

Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis
por: Meier, Stuart, et al.
Publicado: (2022)

Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy
por: Beltran, Caroline G. G., et al.
Publicado: (2020)

Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
por: Malherbe, Stephanus T., et al.
Publicado: (2020)

Human Monocytic Suppressive Cells Promote Replication of Mycobacterium tuberculosis and Alter Stability of in vitro Generated Granulomas
por: Agrawal, Neha, et al.
Publicado: (2018)

Establishment of a Patient-Derived, Magnetic Levitation-Based, Three-Dimensional Spheroid Granuloma Model for Human Tuberculosis
por: Kotze, Leigh A., et al.
Publicado: (2021)

The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
por: Eribo, Osagie A., et al.
Publicado: (2019)

An Archetypical Model for Engrafting Bacteroides fragilis into Conventional Mice Following Reproducible Antibiotic Conditioning of the Gut Microbiota
por: Eribo, Osagie A., et al.
Publicado: (2023)

Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogens
por: Nel, Hendrik J, et al.
Publicado: (2014)

Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
por: Boutzen, Héléna, et al.
Publicado: (2016)

Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1
por: Paubelle, Etienne, et al.
Publicado: (2019)

Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
por: Cassetta, Luca, et al.
Publicado: (2019)

Medroxyprogesterone Acetate Alters Mycobacterium Bovis BCG-Induced Cytokine Production in Peripheral Blood Mononuclear Cells of Contraceptive Users
por: Kleynhans, Léanie, et al.
Publicado: (2011)

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid
por: Steinmetz, Birgit, et al.
Publicado: (2014)

All-trans retinoic acid and genistein induce cell apoptosis in OVCAR-3 cells by increasing the P14 tumor suppressor gene
por: Dastjerdi, Mehdi Nikbakht, et al.
Publicado: (2016)

All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment
por: Su, Meng, et al.
Publicado: (2015)

Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
por: Lin, Yan, et al.
Publicado: (2019)

All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
por: Kim, Yundeok, et al.
Publicado: (2020)

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
por: Ronacher, Katharina, et al.
Publicado: (2019)

Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
por: Fredly, Hanne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_irjchkh0h65s9gmfudftnocl0h